June 9 at 11am – 12:30pm ET (sign up here)

Please join us for a review of key data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. Bloomberg Intelligence analysts Marc Engelsgjerd, MD, and Sam Fazeli, PhD, and inThought Research analyst Matt Presby, PhD, will be joined by expert speakers Patrick Forde, MBBCh, and Ravi Vij, MD, for a discussion of ASCO presentations of interest, including emerging data from checkpoint inhibitors, cell therapies, and targeted small molecules.

Patrick Forde, MBBCh

Director, Thoracic Oncology Clinical Research Program & Associate Professor of Oncology

Johns Hopkins School of Medicine

Dr. Forde treats patients with lung cancer, mesothelioma and other thoracic cancers. He completed training in internal medicine and oncology in Ireland prior to undertaking a further fellowship at Johns Hopkins. He is currently Director of the Thoracic Oncology Clinical Research Program at Johns Hopkins and Associate Member of the Bloomberg-Kimmel Institute for Cancer Immunotherapy. He has led development of a clinical-translational research program focused on the immuno-oncology of upper aerodigestive malignancies.

Ravi Vij, MD

Professor, Department of Medicine, Oncology Division

Washington University School of Medicine in St. Louis

Dr. Vij’s area of academic pursuit is the treatment of hematologic malignancies and hematopoietic stem cell transplantation. He serves on the Core Transplant, Myeloma and Leukemia Committees of the CALGB, the Myeloma Committee of the BMT Clinical Trials Network (CTN) and the Multiple Myeloma Cancer immunotherapy Guideline panel of the Society for Immunotherapy of Cancer. Dr. Vij has served as principal investigator on several national and institutional clinical trials looking at strategies to improve the outcome of patients with multiple myeloma, acute myeloid leukemia and myelodysplastic syndromes and played a role in the development drugs approved for Multiple Myeloma including Carfilzomib, Pomalidomide, Elotuzumab Selinexor and Isatuximab.

Friday, September 18, 2020 11:00 AM EST

Bloomberg Intelligence and inThought host a call with Spinal Muscular Atrophy experts for an in-depth review of the spinal muscular atrophy (SMA) treatment landscape, which now includes approved drugs from Biogen, Novartis and Roche.

Read more

Thursday, April 20, 2020 11:00 AM EST

Bloomberg Intelligence and inThought will host a call with immunology experts Thurs., Apr 20th at 11AM EST to discuss development of a Covid-19 therapy and how best to interpret clinical data once they begin to emerge.

Speakers:

  • Marc Engelsgjerd, MD Senior Analyst, Bloomberg Intelligence
  • Babefemi Taiwo, MBBS Chief of Infection Deseases, Northwestern University Feinberg School of Medicine
  • Eleanor Fish, PhD Professor University of Toronto
  • Amanda Weyerbacher, PhD Senior Principal, inThought Research

Thursday, April 2, 2020 11:00 AM EST / 4:00 PM BST

Please join Bloomberg Intelligence healthcare analysts and inThought Research for a discussion with two vaccine experts, who will share their views on the prospects for developing a vaccine against the novel coronavirus. We will discuss specific programs as well as general considerations for mRNA and other vaccine development.

Read more

With conventions and other events are taking precautions amid the COVID-19 outbreak, some conferences are postponing, while others are providing virtual-only access. Companies are restricting travel for employees, preventing conference attendance. Speakers are unable to attend conventions as many leading academic institutions have restricted physician travel for months. Read more

Networking is critical in almost every industry. In the exceptionally competitive field of healthcare, it is paramount. Medical conferences are an excellent source not only for new clinical data, but also for the latest opinions from physicians. This provides an invaluable look at the future trends for the use of both marketed and pipeline products from biotech and pharmaceutical companies. Here are some tips to help you get the most from attending a pharmaceutical conference. Read more

Competitive intelligence (CI) is a critical component of market intelligence, including market segmentation, opportunity, penetration, and more. In the pharmaceutical industry and other dynamic, capital intensive industries, staying up to date on relevant competitors and market actions is critical. This paper covers some of inThought’s best practices in pharma competitive intelligence. Read more